Total Payments
$166.07
2022 Payments
$14.07
Companies
3
Transactions
17
Medicare Patients
42,815
Medicare Billing
$4.4M
Payment Breakdown by Category
Food & Beverage$166.07 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $166.07 | 17 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $138.17 | 15 | $0 (2017) |
| GE HealthCare | $14.07 | 1 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $13.83 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $14.07 | 1 | GE HealthCare ($14.07) |
| 2019 | $13.83 | 1 | Merck Sharp & Dohme Corporation ($13.83) |
| 2017 | $138.17 | 15 | Allergan Inc. ($138.17) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/14/2022 | GE HealthCare | DaTscan (Drug) | Food and Beverage | Cash or cash equivalent | $14.07 | General |
| Category: Core Imaging | ||||||
| 05/28/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $2.44 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $12.07 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $7.25 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $6.90 | General |
| Category: NEUROSCIENCE | ||||||
| 03/27/2017 | Allergan Inc. | NAMZARIC (Drug) | Food and Beverage | In-kind items and services | $3.30 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $7.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/08/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $3.25 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/23/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $7.75 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/23/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $2.02 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/09/2017 | Allergan Inc. | VIBERZI (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 12,629 | 21,031 | $9.8M | $1.3M |
| 2022 | 7 | 11,881 | 20,143 | $9.3M | $1.2M |
| 2021 | 6 | 10,986 | 17,828 | $8.4M | $1.1M |
| 2020 | 7 | 7,319 | 11,593 | $5.3M | $729,315 |
Total Patients
42,815
Total Services
70,595
Medicare Billing
$4.4M
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 11,610 | 19,642 | $9.4M | $1.2M | 13.1% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2023 | 532 | 611 | $177,190 | $23,642 | 13.3% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 137 | 155 | $68,200 | $16,258 | 23.8% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2023 | 121 | 386 | $46,320 | $9,457 | 20.4% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 198 | 205 | $41,000 | $6,074 | 14.8% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Office | 2023 | 31 | 32 | $13,440 | $2,739 | 20.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 10,884 | 18,639 | $8.9M | $1.2M | 13.0% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2022 | 498 | 609 | $176,610 | $22,540 | 12.8% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2022 | 150 | 168 | $73,970 | $17,645 | 23.9% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2022 | 130 | 488 | $58,560 | $12,012 | 20.5% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2022 | 176 | 193 | $38,600 | $5,818 | 15.1% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Office | 2022 | 32 | 35 | $14,700 | $3,004 | 20.4% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2022 | 11 | 11 | $3,410 | $855.92 | 25.1% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 10,240 | 16,854 | $8.1M | $1.1M | 13.5% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2021 | 482 | 581 | $168,490 | $23,029 | 13.7% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2021 | 144 | 170 | $74,800 | $18,293 | 24.5% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2021 | 38 | 139 | $16,680 | $3,546 | 21.3% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Office | 2021 | 35 | 35 | $14,700 | $2,951 | 20.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2021 | 47 | 49 | $9,800 | $1,525 | 15.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2020 | 6,768 | 10,832 | $5.1M | $692,169 | 13.6% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2020 | 112 | 125 | $54,550 | $12,621 | 23.1% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Office | 2020 | 273 | 323 | $91,110 | $12,408 | 13.6% |
| 88341 | Special stained specimen slides to examine tissue | Office | 2020 | 52 | 192 | $23,040 | $5,072 | 22.0% |
| 88321 | Surgical pathology consultation and report | Office | 2020 | 42 | 43 | $17,010 | $3,818 | 22.4% |
| 88342 | Tissue or cell analysis by immunologic technique | Office | 2020 | 58 | 61 | $12,200 | $1,970 | 16.2% |
About Dr. David Silvers, M.D
Dr. David Silvers, M.D is a Dermatopathology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023118916.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Silvers, M.D has received a total of $166.07 in payments from pharmaceutical and medical device companies, with $14.07 received in 2022. These payments were reported across 17 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($166.07).
As a Medicare-enrolled provider, Silvers has provided services to 42,815 Medicare beneficiaries, totaling 70,595 services with total Medicare billing of $4.4M. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Location New York, NY
- Active Since 09/22/2006
- Last Updated 01/08/2016
- Taxonomy Code 207ND0900X
- Entity Type Individual
- NPI Number 1023118916
Products in Payments
- NAMZARIC (Drug) $98.06
- VIBERZI (Drug) $34.84
- DaTscan (Drug) $14.07
- KEYTRUDA (Biological) $13.83
- LINZESS (Drug) $5.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatopathology Doctors in New York
Dr. Alejandro Gru, Md, MD
Dermatopathology — Payments: $249,067
Dermatopathology $249,067
Dr. Mitchell Mandel, M.d, M.D
Dermatopathology — Payments: $12,844
Dermatopathology $12,844
Tatyana Groysman, D.o, D.O
Dermatopathology — Payments: $7,965
Dermatopathology $7,965
Dr. Travis Hollmann, M.d., Ph.d, M.D., PH.D
Dermatopathology — Payments: $4,436
Dermatopathology $4,436
Robert Phelps, Md, MD
Dermatopathology — Payments: $3,397
Dermatopathology $3,397
Seth Wilentz, Md, MD
Dermatopathology — Payments: $923.07
Dermatopathology $923.07